SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals informs about board meeting

29 Jul 2016 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors will be held on August 12, 2016 to consider and approve the Company’s Unaudited Financial Statements for the First Quarter ended June 30, 2016 (Q1). Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, the trading window closed for Directors and other designated employees of the Company on June 25, 2016 and will remain closed up to August 16, 2016 for the purpose of approval of Unaudited Financial Statements for the First Quarter ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2226.20 -3.45 (-0.15%)
21-Apr-2026 09:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.45
Dr. Reddys Lab 1223.60
Cipla 1230.40
Zydus Lifesciences 929.00
Lupin 2331.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×